US 11,963,967 B2
Phospholipid compounds and uses thereof
Scott E. Lazerwith, San Francisco, CA (US); Jonathan William Medley, San Bruno, CA (US); Philip A. Morganelli, Oakland, CA (US); Thomas P. Stratton, San Francisco, CA (US); and Peiyuan Wang, San Mateo, CA (US)
Assigned to Gilead Sciences, Inc., Foster City, CA (US)
Filed by Gilead Sciences, Inc., Foster City, CA (US)
Filed on Apr. 20, 2023, as Appl. No. 18/304,270.
Application 18/304,270 is a continuation of application No. 17/502,559, filed on Oct. 15, 2021.
Claims priority of provisional application 63/151,456, filed on Feb. 19, 2021.
Claims priority of provisional application 63/093,037, filed on Oct. 16, 2020.
Prior Publication US 2023/0248753 A1, Aug. 10, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/685 (2006.01)
CPC A61K 31/685 (2013.01) 51 Claims
 
1. A compound selected from the group consisting of:

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry
or a pharmaceutically acceptable salt thereof.